Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.4154
-0.0079 (-1.87%)
At close: Feb 24, 2026, 4:00 PM EST
0.4040
-0.0114 (-2.74%)
Pre-market: Feb 25, 2026, 5:28 AM EST
Gossamer Bio Stock Forecast
GOSS's stock price has decreased by -70.33% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts that cover Gossamer Bio stock have a consensus rating of "Buy" and an average price target of $5.90, which forecasts a 1,320.32% increase in the stock price over the next year. The lowest target is $0.30 and the highest is $11.
Price Target: $5.90 (+1,320.32%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gossamer Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 4 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy → Hold Downgrades $6 → $1 | Buy → Hold | Downgrades | $6 → $1 | +140.73% | Feb 24, 2026 |
| Barclays | Barclays | Buy → Sell Downgrades $9 → $0.3 | Buy → Sell | Downgrades | $9 → $0.3 | -27.78% | Feb 24, 2026 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $6 → $1 | Buy → Hold | Downgrades | $6 → $1 | +140.73% | Feb 24, 2026 |
| Barclays | Barclays | Buy Initiates $9 | Buy | Initiates | $9 | +2,066.59% | Jan 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +2,307.32% | Jan 22, 2026 |
Financial Forecast
Revenue This Year
43.04M
from 114.70M
Decreased by -62.48%
Revenue Next Year
45.79M
from 43.04M
Increased by 6.41%
EPS This Year
-0.73
from -0.25
EPS Next Year
-0.59
from -0.73
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 51.6M | 126.4M | ||||
| Avg | 43.0M | 45.8M | ||||
| Low | 34.0M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -55.0% | 193.8% | ||||
| Avg | -62.5% | 6.4% | ||||
| Low | -70.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.62 | -0.21 | ||||
| Avg | -0.73 | -0.59 | ||||
| Low | -0.78 | -0.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.